semaglutide insurance coverage for weight loss A pilot program will cover weight-loss drugs millions of Medicare enrollees for the first time beginning July 1. Read more about who's eligible and what medications are included at the link Insurance coverage just changed for

doi: 10.1002/dta.1941

Although these mechanisms were initially elucidated in patients with T2D, the distinct yet complementary actions of these two drug classes suggest that their combination could provide more comprehensive therapeutic benefits than either agent alone, potentially offering a more effective approach to managing the complex pathophysiology of MASLD and its associated metabolic complications

PMID: 16928994 Loeys BL, Chen J, Neptune ER, Judge DP, Podowski M, Holm T, Meyers J, Leitch CC, Katsanis N, Sharifi N, Xu FL, Myers LA, Spevak PJ, Cameron DE, De Backer J, Hellemans J, Chen Y, Davis EC, Webb CL, Kress W, Coucke P, Rifkin DB, De Paepe AM, Dietz HC

However, participants given apitegromab alongside tirzepatide lost on average 1.6kg (3.5lb) of lean mass (corresponding to 14.6% of total weight loss) while those given tirzepatide alongside a placebo lost on average 3.5kg of lean mass

Cani PD, Lecourt E, Dewulf EM, et al

Understanding what each agent is and what it is not is essential before drawing any meaningful comparison